Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.7100
+0.3100 (77.50%)
At close: Jul 31, 2026
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $3.92 million as of July 31, 2026. Its market cap has decreased by -40.32% in one year.
Market Cap
3.92M
Enterprise Value
22.07M
Revenue
1.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.71
ChartMarket Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 3.92M, an increase of 1,449.76%. That is a compound annual growth rate of 18.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.92M | 298.83% |
| Dec 31, 2025 | 982.83K | -89.94% |
| Dec 31, 2024 | 9.77M | -38.79% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 5.38M |
| LianMedical | 4.87M |
| GPL Holdings | 4.20M |
| Mosaic ImmunoEngineering | 3.98M |
| Institute of Biomedical Research | 3.30M |
| Eastgate Biotech | 3.17M |
| Vaccinex | 3.16M |
| Pacific Software | 3.12M |